Fully Automated GMP-Compliant Synthesis of [18F]FE-PE2I.
Ontology highlight
ABSTRACT: In the struggle to understand and accurately diagnose Parkinson's disease, radiopharmaceuticals and medical imaging techniques have played a major role. By being able to image and quantify the dopamine transporter density, noninvasive diagnostic imaging has become the gold standard. In the shift from the first generation of SPECT tracers, the fluorine-18-labeled tracer [18F]FE-PE2I has emerged as the agent of choice for many physicians. However, implementing suitable synthesis for the production of [18F]FE-PE2I has proved more challenging than expected. Through a thorough analysis of the relevant factors affecting the final radiochemical yield, we were able to implement high-yielding fully automated GMP-compliant synthesis of [18F]FE-PE2I on a Synthera
SUBMITTER: Bratteby K
PROVIDER: S-EPMC8308591 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA